Chloroquine and Hydroxychloroquine Binding to Melanin: Some Possible Consequences for Pathologies

Overview

Journal Toxicol Rep

Date 2017 Oct 1

PMID 28962308

Citations 37

Authors

R L Schroeder

J P Gerber

Affiliations

Soon will be listed here.

Abstract

For many years chloroquine was used as a prophylactic agent against malaria, and more recently as a mild immunosuppressive. However, due to lengthy treatment periods, adverse effects have become apparent, which included retinopathy. The structurally related hydroxychloroquine is less toxic, thought to be owing to a lower tissue accumulation in melanin rich areas. This study primarily focused on quantifying melanin binding between chloroquine and hydroxychloroquine at physiological pH to investigate the potential link between binding and reported toxicity. In addition, for the first time this study quantified the actual extent of adsorption of chloroquine and hydroxychloroquine to melanin and examined the desorption profile of both drugs from melanin to demonstrate the affinity between the pigment and the solutes. The results suggest that there is a difference between the adsorption affinities of chloroquine and hydroxychloroquine, potentially explaining the differences in bioaccumulation in retinal tissue. In addition, both solutes displayed a strong physical attraction to the absorbent.

Citing Articles

Novel electroretinography devices to detect hydroxychloroquine retinopathy: study protocol for a diagnostic accuracy and feasibility study.

Lee C, Wafa H, Murphy G, Galloway J, Mahroo O, Jackson T BMJ Open Ophthalmol. 2024; 9(1.

PMID: 39719323 PMC: 11683940. DOI: 10.1136/bmjophth-2024-001898.

Mathematical Models of Ocular Drug Delivery.

Sadeghi A, Subrizi A, Del Amo E, Urtti A Invest Ophthalmol Vis Sci. 2024; 65(11):28.

PMID: 39287588 PMC: 11412384. DOI: 10.1167/iovs.65.11.28.

Melanin Biopolymers in Pharmacology and Medicine-Skin Pigmentation Disorders, Implications for Drug Action, Adverse Effects and Therapy.

Karkoszka M, Rok J, Wrzesniok D Pharmaceuticals (Basel). 2024; 17(4).

PMID: 38675481 PMC: 11054731. DOI: 10.3390/ph17040521.

Impaired Lysosome Reformation in Chloroquine-Treated Retinal Pigment Epithelial Cells.

Cardoso M, Hall M, Burgoyne T, Fale P, Storm T, Escrevente C Invest Ophthalmol Vis Sci. 2023; 64(11):10.

PMID: 37548963 PMC: 10411645. DOI: 10.1167/iovs.64.11.10.

Hydroxychloroquine-induced Retinal Toxicity.

Yusuf I, Charbel Issa P, Ahn S Front Pharmacol. 2023; 14:1196783.

PMID: 37324471 PMC: 10267834. DOI: 10.3389/fphar.2023.1196783.

References

Warhurst D, Steele J, Adagu I, Craig J, Cullander C . Hydroxychloroquine is much less active than chloroquine against chloroquine-resistant Plasmodium falciparum, in agreement with its physicochemical properties. J Antimicrob Chemother. 2003; 52(2):188-93. DOI: 10.1093/jac/dkg319. View

Li Q, Clarke J, Gao K, Zhou C, Meng Q, Li D . Melanosome evolution indicates a key physiological shift within feathered dinosaurs. Nature. 2014; 507(7492):350-3. DOI: 10.1038/nature12973. View

Tsuchiya M, Hayasaka S, Mizuno K . Affinity of ocular acid-insoluble melanin for drugs in vitro. Invest Ophthalmol Vis Sci. 1987; 28(5):822-5. View

Larsson B, Oskarsson A, Tjalve H . On the binding of the bisquaternary ammonium compound paraquat to melanin and cartilage in vivo. Biochem Pharmacol. 1978; 27(13):1721-4. DOI: 10.1016/0006-2952(78)90546-4. View

Krafts K, Hempelmann E, Skorska-Stania A . From methylene blue to chloroquine: a brief review of the development of an antimalarial therapy. Parasitol Res. 2012; 111(1):1-6. DOI: 10.1007/s00436-012-2886-x. View

Cooper R, Magwere T . Chloroquine: novel uses & manifestations. Indian J Med Res. 2008; 127(4):305-16. View

Patil P, Shimada K, Feller D, Malspeis L . Accumulation of (-)-14C-ephedrine by the pigmented and the nonpigmented iris. J Pharmacol Exp Ther. 1974; 188(2):342-52. View

Tjalve H, Nilsson M, Larsson B . Studies on the binding of chlorpromazine and chloroquine to melanin in vivo. Biochem Pharmacol. 1981; 30(13):1845-7. DOI: 10.1016/0006-2952(81)90021-6. View

Stepien K, Wilczok T . Studies of the mechanism of chloroquine binding to synthetic DOPA-melanin. Biochem Pharmacol. 1982; 31(21):3359-65. DOI: 10.1016/0006-2952(82)90612-8. View

10.

Shimada K, Baweja R, Sokoloski T, Patil P . Binding characteristics of drugs to synthetic levodopa melanin. J Pharm Sci. 1976; 65(7):1057-60. DOI: 10.1002/jps.2600650725. View

11.

Madaras F, Gerber J, Peddie F, Kokkinn M . The effect of sampling methods on the apparent constituents of ink from the squid Sepioteuthis australis. J Chem Ecol. 2010; 36(11):1171-9. DOI: 10.1007/s10886-010-9869-0. View

12.

Wallace D . The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review. Lupus. 1996; 5 Suppl 1:S59-64. View

13.

Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A . DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2010; 39(Database issue):D1035-41. PMC: 3013709. DOI: 10.1093/nar/gkq1126. View

14.

Tzekov R . Ocular toxicity due to chloroquine and hydroxychloroquine: electrophysiological and visual function correlates. Doc Ophthalmol. 2005; 110(1):111-20. DOI: 10.1007/s10633-005-7349-6. View

15.

Bridelli M, Ciati A, Crippa P . Binding of chemicals to melanins re-examined: adsorption of some drugs to the surface of melanin particles. Biophys Chem. 2005; 119(2):137-45. DOI: 10.1016/j.bpc.2005.06.004. View

16.

POTTS A . The concentration of phenothiazines in the eye of experimental animals. Invest Ophthalmol. 1962; 1:522-30. View

17.

Easterbrook M . The ocular safety of hydroxychloroquine. Semin Arthritis Rheum. 1993; 23(2 Suppl 1):62-7. DOI: 10.1016/s0049-0172(10)80009-5. View

18.

Michaelides M, Stover N, Francis P, Weleber R . Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy. Arch Ophthalmol. 2011; 129(1):30-9. DOI: 10.1001/archophthalmol.2010.321. View

19.

Patil P . Cocaine-binding by the pigmented and the nonpigmented iris and its relevance to the mydriatic effect. Invest Ophthalmol. 1972; 11(9):739-46. View

20.

Ings R . The melanin binding of drugs and its implications. Drug Metab Rev. 1984; 15(5-6):1183-212. DOI: 10.3109/03602538409033561. View